{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:27:17Z","timestamp":1773800837951,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To evaluate proton beam therapy (PBT) in multimodal treatment for locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus (NPSCC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The cases in this study included T3 and T4 NPSCC without distant metastases that were treated at our center using PBT between July 2003 and December 2020. These cases were classified into 3 groups based on resectability and treatment strategy: surgery followed by postoperative PBT (group A); those indicated to be resectable, but the patient refused surgery and received radical PBT (group B); and those declared unresectable based on the extent of the tumor and treated with radical PBT (group C).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study included 37 cases, with 10, 9 and 18 in groups A, B and C, respectively. The median follow-up period in surviving patients was 4.4 years (range 1.0-12.3 years). The 4-year overall survival (OS), progression-free survival (PFS), and local control (LC) rates were 58%, 43% and 58% for all patients; 90%, 70% and 80% in group A, 89%, 78% and 89% in group B; and 24%, 11% and 24% in group C. There were significant differences in OS (p\u2009=\u20090.0028) and PFS (p\u2009=\u20090.009) between groups A and C; and in OS (p\u2009=\u20090.0027), PFS (p\u2009=\u20090.0045) and LC (p\u2009=\u20090.0075) between groups B and C.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PBT gave favorable outcomes in multimodal treatment for resectable locally advanced NPSCC, including surgery followed by postoperative PBT and radical PBT with concurrent chemotherapy. The prognosis for unresectable NPSCC was extremely poor, and reconsideration of treatment strategies, such as more active use of induction chemotherapy, may improve outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-023-02296-3","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T16:02:32Z","timestamp":1688054552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proton beam therapy in multimodal treatment for locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus"],"prefix":"10.1186","volume":"18","author":[{"given":"Takashi","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuho","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"2296_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2273.1980.tb01647.x","volume":"5","author":"CS Muir","year":"1980","unstructured":"Muir CS, Nectoux J. Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses. Clin Otolaryngol Allied Sci. 1980;5:195\u2013211.","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"2296_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/hed.21830","volume":"34","author":"JH Turner","year":"2012","unstructured":"Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34:877\u201385.","journal-title":"Head Neck"},{"key":"2296_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S1470-2045(14)70268-2","volume":"15","author":"SH Patel","year":"2014","unstructured":"Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1027\u201338.","journal-title":"Lancet Oncol"},{"key":"2296_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijrobp.2016.02.042","volume":"95","author":"AL Russo","year":"2016","unstructured":"Russo AL, Adams JA, Weyman EA, Busse PM, Goldberg SI, Varvares M, et al. Long-term outcomes after proton beam therapy for sinonasal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2016;95:368\u201376.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2296_CR5","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.ijrobp.2018.04.041","volume":"101","author":"Y Toyomasu","year":"2018","unstructured":"Toyomasu Y, Demizu Y, Matsuo Y, Sulaiman NS, Mima M, Nagano F, et al. Outcomes of patients with sinonasal squamous cell carcinoma treated with particle therapy using protons or carbon ions. Int J Radiat Oncol Biol Phys. 2018;101:1096\u2013103.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2296_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.clon.2023.02.009","volume":"35","author":"E Hwang","year":"2023","unstructured":"Hwang E, Gaito S, France A, Crellin AM, Thwaites DI, Ahern V, et al. Outcomes of patients treated in the UK Proton Overseas Programme: non-central nervous System Group. Clin Oncol. 2023;35:292\u2013300.","journal-title":"Clin Oncol"},{"key":"2296_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.clon.2023.01.024","volume":"35","author":"S Gaito","year":"2023","unstructured":"Gaito S, Hwang EJ, France A, Aznar MC, Burnet N, Crellin A, et al. Outcomes of patients treated in the UK Proton Overseas Programme: Central Nervous System Group. Clin Oncol. 2023;35:283\u201391.","journal-title":"Clin Oncol"},{"key":"2296_CR8","doi-asserted-by":"crossref","unstructured":"Brierley JD. In: Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours, Eighth edition. John Wiley & Sons; 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"2296_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.oraloncology.2012.07.009","volume":"49","author":"X Guan","year":"2013","unstructured":"Guan X, Wang X, Liu Y, Hu C, Zhu G. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT\/3D-CRT. Oral Oncol. 2013;49:60\u20135.","journal-title":"Oral Oncol"},{"key":"2296_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13014-015-0496-3","volume":"10","author":"S Duru Birgi","year":"2015","unstructured":"Duru Birgi S, Teo M, Dyker KE, Sen M, Prestwich RJD. Definitive and adjuvant radiotherapy for sinonasal squamous cell carcinomas: a single institutional experience. Radiat Oncol. 2015;10:190.","journal-title":"Radiat Oncol"},{"key":"2296_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.5301\/tj.5000431","volume":"102","author":"S-H Park","year":"2016","unstructured":"Park S-H, Lee JE, Ahn D. Outcome of definitive and postoperative radiotherapy in patients with sinonasal squamous cell carcinomas. Tumori. 2016;102:426\u201332.","journal-title":"Tumori"},{"key":"2296_CR12","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jcms.2017.05.006","volume":"45","author":"A Par\u00e9","year":"2017","unstructured":"Par\u00e9 A, Blanchard P, Rosellini S, Aup\u00e9rin A, Gorphe P, Casiraghi O, et al. Outcomes of multimodal management for sinonasal squamous cell carcinoma. J Craniomaxillofac Surg. 2017;45:1124\u201332.","journal-title":"J Craniomaxillofac Surg"},{"key":"2296_CR13","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1016\/j.clon.2021.05.012","volume":"33","author":"F Slevin","year":"2021","unstructured":"Slevin F, Pan S, Mistry H, Denholm M, Shor D, Oong Z, et al. A Multicentre UK Study of outcomes for locally advanced sinonasal squamous cell carcinoma treated with adjuvant or definitive intensity-modulated radiotherapy. Clin Oncol. 2021;33:e450\u201361.","journal-title":"Clin Oncol"},{"key":"2296_CR14","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/cncr.33452","volume":"127","author":"AS Abdelmeguid","year":"2021","unstructured":"Abdelmeguid AS, Teeramatwanich W, Roberts DB, Amit M, Ferraroto R, Glisson BS, et al. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses. Cancer. 2021;127:1788\u201395.","journal-title":"Cancer"},{"key":"2296_CR15","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1007\/s00405-019-05601-7","volume":"276","author":"R Li","year":"2019","unstructured":"Li R, Tian S, Lin L, Liu Q, Wang S. Comparative outcome of surgical and nonsurgical therapy for T4bN0M0 sinonasal squamous cell carcinomas. Eur Arch Otorhinolaryngol. 2019;276:3113\u201322.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2296_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40463-018-0310-y","volume":"47","author":"P Sittitrai","year":"2018","unstructured":"Sittitrai P, Reunmarkkaew D, Chaiyasate S. The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series. J Otolaryngol Head Neck Surg. 2018;47:62.","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"2296_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/jjco\/hyw064","volume":"46","author":"N-X Chen","year":"2016","unstructured":"Chen N-X, Chen L, Wang J-L, Wang J-Y, Yan F, Ma L, et al. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus. Jpn J Clin Oncol. 2016;46:727\u201334.","journal-title":"Jpn J Clin Oncol"},{"key":"2296_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/archoto.2010.231","volume":"137","author":"EY Hanna","year":"2011","unstructured":"Hanna EY, Cardenas AD, DeMonte F, Roberts D, Kupferman M, Weber R, et al. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2011;137:78\u201381.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2296_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3904\/kjim.2015.020","volume":"31","author":"C-Y Ock","year":"2016","unstructured":"Ock C-Y, Keam B, Kim TM, Han DH, Won T-B, Lee S-H, et al. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. Korean J Intern Med. 2016;31:570\u20138.","journal-title":"Korean J Intern Med"},{"key":"2296_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10147-014-0737-8","volume":"20","author":"S Zenda","year":"2015","unstructured":"Zenda S, Kawashima M, Arahira S, Kohno R, Nishio T, Tahara M, et al. Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up. Int J Clin Oncol. 2015;20:447\u201354.","journal-title":"Int J Clin Oncol"},{"key":"2296_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.clon.2021.03.009","volume":"33","author":"S Gaito","year":"2021","unstructured":"Gaito S, Abravan A, Richardson J, Lowe M, Indelicato DJ, Burnet N, et al. Skin toxicity profile of photon radiotherapy versus proton beam therapy in paediatric and young adult patients with sarcomas. Clin Oncol. 2021;33:507\u201316.","journal-title":"Clin Oncol"},{"issue":"3","key":"2296_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.14338\/IJPT-22-00011.1","volume":"9","author":"E Foster-Thomas","year":"2023","unstructured":"Foster-Thomas E, Aznar M, Indelicato D, Pan S, Hwang E, Sitch P, et al. Late dental toxicities after proton chemoradiation for rhabdomyosarcoma: a pediatric case report. Int J Part Ther. 2023;9(3):50\u20137.","journal-title":"Int J Part Ther"},{"key":"2296_CR23","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1016\/j.clon.2021.05.002","volume":"33","author":"S Gaito","year":"2021","unstructured":"Gaito S, France A, Foden P, Abravan A, Burnet N, Garcez K, et al. A predictive model for reactive tube feeding in head and neck cancer patients undergoing definitive (chemo) radiotherapy. Clin Oncol. 2021;33:e433\u201341.","journal-title":"Clin Oncol"},{"key":"2296_CR24","doi-asserted-by":"publisher","first-page":"20211175","DOI":"10.1259\/bjr.20211175","volume":"95","author":"NG Burnet","year":"2022","unstructured":"Burnet NG, Mee T, Gaito S, Kirkby NF, Aitkenhead AH, Anandadas CN, et al. Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy. BJR Suppl. 2022;95:20211175.","journal-title":"BJR Suppl"},{"key":"2296_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clon.2021.09.010","volume":"34","author":"E Hwang","year":"2022","unstructured":"Hwang E, Burnet NG, Crellin AM, Ahern V, Thwaites DI, Gaito S, et al. A novel model and infrastructure for clinical outcomes data collection and their systematic evaluation for UK patients receiving proton beam therapy. Clin Oncol. 2022;34:11\u20138.","journal-title":"Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02296-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02296-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02296-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T16:04:41Z","timestamp":1688054681000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02296-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2296"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02296-3","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the Ethical Review Committee and the University of Tsukuba Hospital Steering Committee (R04-155).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}